Algenpantucel-L

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameAlgenpantucel-L
Drug Alias NamePancreatic cancer vaccine - NewLink GeneticsHyperAcute PancreasHAPa
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNewlink Genetics Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewlink Genetics Co
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A